The path to a Billion Dollar + company, page-167

It is like being trapped in a small elevator with a schizophrenic claustrophobic.

Facts

1) Outside of us and a handful of others, at the moment, no-one else gives a monkeys about IXC.
2) Management are most welcome to buy stock but it will not have any durable effect on the shareprice and will give no indication as to the outcome of the P3 trials.
3) Most investors in non revenue small cap pharma are down hugely over the last 3 months, on a relative basis we are close to the top of the tree.
4) There have been numerous times in the last 30 years where small cap pharma development companies trade below (sometimes well below) their net cash postion.
5) Hedge funds and many retail investors are puking their guts at the moment and selling not just what they wont to but what they can, in order to square their margin positions. Adding new exposure is far from their minds.
6) If you examine every trade as if it has some predictive power about the future of IXC, one will, as someone said earlier, stroke out

All of that said there is enormous potential here over the next 3 or 4 years but there is not a snowballs chance in hell that that this will be properly reflected in the shareprice until we are close to or have a readout on phase 3. So I hope you all have a decent book and a few cold one to help you pass the time, because for the next little at least, the significant and real potential embedded within IXC is going to be out little secret